Little Green Pharma (ASX:LGP) - Managing Director, Fleta Solomon
Managing Director, Fleta Solomon
Source: LGP
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Little Green Pharma (LGP) enters an exclusive agreement with PharmaServe for the distribution of LGP-branded oil medicines and cannabis flower in Greece
  • PharmaServe will exclusively distribute LGP medicines for at least two years under the agreement
  • In return, the company will only distribute its cannabis medicine through PharmaServe in Greece
  • The companies will share product revenue equally, subject to LGP receiving a certain minimum prices per unit
  • Shares are trading up 0.84 per cent to 60 cents

Little Green Pharma (LGP) has entered into an exclusive agreement with PharmaServe for the distribution of LGP-branded oil medicines and cannabis flower in Greece.

PharmaServe will exclusively distribute LGP medicines for at least two years under the agreement, with further exclusivity periods to be extended by agreement.

In return, the company will only distribute its cannabis medicine through PharmaServe in Greece for the same two year period.

This obligation is conditional upon PharmaServe achieving revenues of at least €600,000 (A$945,000) per year. There are no minimum quantity commitments under the Agreement.

The agreement is also conditional upon PharmaServe obtaining a marketing authorisation to distribute the LGP cannabis medicines in Greece.

Little Green Pharma will supply the medicines from its Australian and Danish facilities.

The companies will share product revenue equally, subject to LGP receiving a certain minimum price per unit.

There are no current registered medicinal cannabis products in Greece which the company believes will give it a significant foothold in a new, under-served market in Europe.

Chief Executive Officer Fleta Solomon said she is thrilled to expand distribution to Greece.

“The Agreement represents the continued fulfilment of LGP’s strategic imperative
to grow significant market shares in key markets across the EU,” she said.

“With the addition of Greece to the LGP distribution footprint, LGP aims to capture a market that is currently significantly underserved and overlooked by other medicinal cannabis producers.

“With a population of 11 million and no currently registered cannabis medicines, the market for medicinal cannabis in Greece represents another attractive opportunity for LGP’s broader international growth ambitions.”

Shares were trading in the green today, up 0.84 per cent to 59.5 cents each at 3.02 pm AEDT.

LGP by the numbers
More From The Market Online
The Market Online Video

Market Close: ASX200 closes higher on interest rates pause

The ASX200 spiked straight after the Reserve Bank of Australia announced it’ll hold interest rates at…

The Calmer Co has shipped its Fiji Kava health shots to Australia

The Calmer Co (ASX:CCO) has confirmed its Kava-based health drink products have been shipped to Coles…

The Calmer Co’s FijiKava now at USA’s Walmart

Not long after hitting the shelves at Coles, Calmer Co's Fiji Kava products have hit the…
The Market Online Video

Webinar: Australia’s Uranium Awakening: Investing in a Glowing Future

Uranium's regained serious value after an extended price depression that resulted from plentiful supplies coupled with…